Cargando…
HPV genotype determination and E6/E7 mRNA detection for management of HPV positive women
BACKGROUND: Clinical management of HPV positive women is difficult since many of the infections, including high-risk oncogene genotypes (hr-HPV), are transient. Therefore only a limited number of patients have a high-grade lesion and sending all HPV positive women for colposcopy would only increase...
Autores principales: | Bruno, Maria Teresa, Ferrara, Martina, Fava, Valentina, Rapisarda, Agnese, Coco, Angela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870089/ https://www.ncbi.nlm.nih.gov/pubmed/29587778 http://dx.doi.org/10.1186/s12985-018-0957-z |
Ejemplares similares
-
HPV16 E6/E7 -based mRNA vaccine is therapeutic in mice bearing aggressive HPV-positive lesions
por: Zhou, Kun, et al.
Publicado: (2023) -
The Expression of HPV E6/E7 mRNA In Situ Hybridization in HPV Typing-negative Cervical Cancer
por: Xu, Yating, et al.
Publicado: (2023) -
Predictive Value of HPV E6/E7 mRNA Detection on the Outcome of Cervical LSIL
por: Cao, Limei, et al.
Publicado: (2022) -
Diagnostic value of high-risk HPV E6/E7 mRNA in patients with ASCUS
por: Jin, Xiu, et al.
Publicado: (2023) -
Diversity of cervicovaginal human papillomavirus (HPV) genotypes and naturally occurring E6/E7 DNA polymorphisms of HPV-16 in Ghana
por: Kaba, Gladys, et al.
Publicado: (2023)